Jerry Adams

Q: What Schools Are Affiliated With Jerry Adams

Jerry Adams is affiliated with the following schools: Harvard University, University of Innsbruck, University of California, Berkeley, Emory University, University of Melbourne, Stanford University

Jerry Adams's AcademicInfluence.com Rankings

Jerry Adams

Biology

#1400

World Rank

#2356

Historical Rank

#705

USA Rank

Cell Biology

#126

World Rank

#131

Historical Rank

#43

USA Rank

Molecular Biology

#159

World Rank

#163

Historical Rank

#83

USA Rank

Genetics

#163

World Rank

#202

Historical Rank

#94

USA Rank

biology Degrees

Download Badge

Biology

Jerry Adams's Degrees

PhD Molecular Biology Stanford University

Why Is Jerry Adams Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Jerry McKee Adams, FAA, FRS, FAHMS, FRSV is an Australian-American molecular biologist whose research into the genetics of haemopoietic differentiation and malignancy, led him and his wife, Professor Suzanne Cory, to be the first two scientists to pioneer gene cloning techniques in Australia, and to successfully clone mammalian genes.

(See a Problem?)

Jerry Adams's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

The Bcl-2 protein family: arbiters of cell survival. (1998) (5526)
The Bcl2 family: regulators of the cellular life-or-death switch (2002) (3840)
Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells (1988) (3273)
Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy (2013) (2438)
The Bcl-2 apoptotic switch in cancer development and therapy (2007) (2047)
Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function. (2005) (1793)
The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice (1985) (1744)
Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. (1999) (1633)
The Bcl-2 family: roles in cell survival and oncogenesis (2003) (1492)
p53- and Drug-Induced Apoptotic Responses Mediated by BH3-Only Proteins Puma and Noxa (2003) (1358)
Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins. (2005) (1313)
The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized. (2006) (1223)
Apoptosis Initiated When BH3 Ligands Engage Multiple Bcl-2 Homologs, Not Bax or Bak (2007) (1210)
Bim: a novel member of the Bcl‐2 family that promotes apoptosis (1998) (1161)
Life-or-death decisions by the Bcl-2 protein family. (2001) (924)
Tumor Growth Need Not Be Driven by Rare Cancer Stem Cells (2007) (879)
Enforced BCL2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease. (1991) (852)
BH3-only Bcl-2 family member Bim is required for apoptosis of autoreactive thymocytes (2002) (822)
Ways of dying: multiple pathways to apoptosis. (2003) (817)
Life in the balance: how BH3-only proteins induce apoptosis. (2005) (781)
Bcl-2-regulated apoptosis: mechanism and therapeutic potential. (2007) (633)
Apoptosis initiated by Bcl-2-regulated caspase activation independently of the cytochrome c/Apaf-1/caspase-9 apoptosome (2002) (569)
Novel zinc finger gene implicated as myc collaborator by retrovirally accelerated lymphomagenesis in Eμ-myc transgenic mice (1991) (546)
Deciphering the rules of programmed cell death to improve therapy of cancer and other diseases (2011) (480)
Bax Crystal Structures Reveal How BH3 Domains Activate Bax and Nucleate Its Oligomerization to Induce Apoptosis (2013) (478)
The c-myc oncogene perturbs B lymphocyte development in Eμ-myc transgenic mice (1986) (449)
The E mu-myc transgenic mouse. A model for high-incidence spontaneous lymphoma and leukemia of early B cells (1988) (422)
Slug Antagonizes p53-Mediated Apoptosis of Hematopoietic Progenitors by Repressing puma (2005) (418)
Modified nucleosides and bizarre 5′-termini in mouse myeloma mRNA (1975) (379)
Constitutive Bcl-2 expression throughout the hematopoietic compartment affects multiple lineages and enhances progenitor cell survival. (1999) (376)
Sequence of the murine and human cellular myc oncogenes and two modes of myc transcription resulting from chromosome translocation in B lymphoid tumours. (1983) (346)
bcl-w, a novel member of the bcl-2 family, promotes cell survival. (1996) (330)
Murine T lymphomas in which the cellular myc oncogene has been activated by retroviral insertion (1984) (329)
Apoptosis regulator bcl-w is essential for spermatogenesis but appears otherwise redundant. (1998) (328)
To trigger apoptosis, Bak exposes its BH3 domain and homodimerizes via BH3:groove interactions. (2008) (318)
Structure-guided design of a selective BCL-X(L) inhibitor. (2013) (314)
Apoptosomes: engines for caspase activation. (2002) (310)
Transgenic models of tumor development. (1991) (291)
BH3-only proteins Puma and Bim are rate-limiting for gamma-radiation- and glucocorticoid-induced apoptosis of lymphoid cells in vivo. (2005) (289)
Key roles of BIM-driven apoptosis in epithelial tumors and rational chemotherapy. (2005) (287)
Degenerative disorders caused by Bcl-2 deficiency prevented by loss of its BH3-only antagonist Bim. (2001) (277)
Cellular myc oncogene is altered by chromosome translocation to an immunoglobulin locus in murine plasmacytomas and is rearranged similarly in human Burkitt lymphomas. (1983) (276)
The conserved N‐terminal BH4 domain of Bcl‐2 homologues is essential for inhibition of apoptosis and interaction with CED‐4 (1998) (262)
On the release of the formyl group from nascent protein. (1968) (255)
The anti‐apoptotic activities of Rel and RelA required during B‐cell maturation involve the regulation of Bcl‐2 expression (2000) (247)
The BCL-2 arbiters of apoptosis and their growing role as cancer targets (2017) (243)
Is tumor growth sustained by rare cancer stem cells or dominant clones? (2008) (223)
Killing cancer cells by flipping the Bcl-2/Bax switch. (2005) (206)
bmi-1 transgene induces lymphomas and collaborates with myc in tumorigenesis. (1993) (200)
The role of BH3-only protein Bim extends beyond inhibiting Bcl-2–like prosurvival proteins (2009) (194)
Bak activation for apoptosis involves oligomerization of dimers via their alpha6 helices. (2009) (194)
In several cell types tumour suppressor p53 induces apoptosis largely via Puma but Noxa can contribute (2008) (193)
Egalitarian binds dynein light chain to establish oocyte polarity and maintain oocyte fate (2004) (191)
Homeobox gene expression plus autocrine growth factor production elicits myeloid leukemia. (1990) (188)
Hemopoietic lineage switch: v-raf oncogene converts Eμmyc transgenic B cells into macrophages (1988) (186)
Bcl-2 has a cell cycle inhibitory function separable from its enhancement of cell survival. (1996) (183)
Hlx homeo box gene is essential for an inductive tissue interaction that drives expansion of embryonic liver and gut. (1996) (182)
The proteasome inhibitor bortezomib sensitizes cells to killing by death receptor ligand TRAIL via BH3-only proteins Bik and Bim (2005) (179)
bcr-abl oncogene renders myeloid cell line factor independent: potential autocrine mechanism in chronic myeloid leukemia. (1988) (175)
Bcl-2 family members do not inhibit apoptosis by binding the caspase activator Apaf-1. (1999) (173)
Insights from Bcl-2 and Myc: malignancy involves abrogation of apoptosis as well as sustained proliferation. (1999) (165)
The C-terminal zinc finger of GATA-1 or GATA-2 is sufficient to induce megakaryocytic differentiation of an early myeloid cell line (1995) (165)
Evidence That Focal Adhesion Complexes Power Bacterial Gliding Motility (163)
Promoter elements of vav drive transgene expression in vivo throughout the hematopoietic compartment. (1999) (162)
Apoptosis is triggered when prosurvival Bcl-2 proteins cannot restrain Bax (2008) (160)
Expression of multiple homeobox genes within diverse mammalian haemopoietic lineages. (1988) (159)
Differential expression of the LYL, SCL and E2A helix-loop-helix genes within the hemopoietic system. (1991) (158)
The hematopoietically expressed vav proto-oncogene shares homology with the dbl GDP-GTP exchange factor, the bcr gene and a yeast gene (CDC24) involved in cytoskeletal organization. (1992) (157)
Bcl-2 Retards Cell Cycle Entry through p27Kip1, pRB Relative p130, and Altered E2F Regulation (2000) (156)
Variant (6;15) translocations in murine plasmacytomas involve a chromosome 15 locus at least 72 kb from the c‐myc oncogene. (1985) (156)
Gene structure, alternative splicing, and chromosomal localization of pro-apoptotic Bcl-2 relative Bim (2001) (155)
The Role of Bim, a Proapoptotic BH3‐Only Member of the Bcl‐2 Family, in Cell‐Death Control (2000) (153)
Puma and to a lesser extent Noxa are suppressors of Myc-induced lymphomagenesis (2009) (152)
The BCL-2 arbiters of apoptosis and their growing role as cancer targets. (2018) (150)
Pro-Apoptotic Apoptosis Protease–Activating Factor 1 (Apaf-1) Has a Cytoplasmic Localization Distinct from Bcl-2 or Bcl-XL (2000) (143)
PU.1 is a suppressor of myeloid leukemia, inactivated in mice by gene deletion and mutation of its DNA binding domain. (2004) (137)
Expression of the immunoglobulin C mu gene in mouse T and B lymphoid and myeloid cell lines. (1980) (137)
Abnormalities of the immune system induced by dysregulated bcl-2 expression in transgenic mice. (1990) (135)
Absence of p53 allows direct immortalization of hematopoietic cells by the myc and raf oncogenes (1995) (132)
Mitochondrial permeabilization relies on BH3 ligands engaging multiple prosurvival Bcl-2 relatives, not Bak (2007) (130)
Chromosome 8 breakpoint far 3′ of the c‐myc oncogene in a Burkitt's lymphoma 2;8 variant translocation is equivalent to the murine pvt‐1 locus. (1986) (128)
Murine T lymphomas with retroviral inserts in the chromosomal 15 locus for plasmacytoma variant translocations (1985) (124)
Apoptosis-promoted tumorigenesis: gamma-irradiation-induced thymic lymphomagenesis requires Puma-driven leukocyte death. (2010) (124)
A bcr-v-abl oncogene induces lymphomas in transgenic mice (1989) (124)
Proapoptotic BH3-only proteins trigger membrane integration of prosurvival Bcl-w and neutralize its activity (2003) (123)
Transgenic mice and oncogenesis. (1988) (120)
Deletions are associated with somatic rearrangement of immunoglobulin heavy chain genes (1980) (119)
Expression of Hox-2.4 homeobox gene directed by proviral insertion in a myeloid leukemia. (1989) (117)
Proapoptotic BH3-Only Bcl-2 Family Member Bik/Blk/Nbk Is Expressed in Hemopoietic and Endothelial Cells but Is Redundant for Their Programmed Death (2004) (115)
N‐myc transgene promotes B lymphoid proliferation, elicits lymphomas and reveals cross‐regulation with c‐myc. (1989) (113)
Ultraviolet radiation triggers apoptosis of fibroblasts and skin keratinocytes mainly via the BH3-only protein Noxa (2007) (111)
Megakaryocytic differentiation induced in 416B myeloid cells by GATA-2 and GATA-3 transgenes or 5-azacytidine is tightly coupled to GATA-1 expression. (1993) (109)
Targeting BCL-2-like Proteins to Kill Cancer Cells. (2016) (104)
Apoptotic pore formation is associated with in-plane insertion of Bak or Bax central helices into the mitochondrial outer membrane (2014) (103)
Bcl-2–regulated apoptosis and cytochrome c release can occur independently of both caspase-2 and caspase-9 (2004) (101)
Novel murine homeo box gene on chromosome 1 expressed in specific hematopoietic lineages and during embryogenesis. (1991) (100)
Transcriptionally active DNA region that rearranges frequently in murine lymphoid tumors. (1982) (97)
Transcriptional regulation of vav, a gene expressed throughout the hematopoietic compartment. (1998) (96)
cDNA sequence for human bcr, the gene that translocates to the abl oncogene in chronic myeloid leukaemia. (1987) (89)
Translocation of the myc cellular oncogene to the immunoglobulin heavy chain locus in murine plasmacytomas is an imprecise reciprocal exchange (1984) (88)
Proviral integration site Mis-1 in rat thymomas corresponds to the pvt-1 translocation breakpoint in murine plasmacytomas (1986) (79)
Transgenic models of lymphoid neoplasia and development of a pan-hematopoietic vector (1999) (78)
Transcripts of the immunoglobulin C mu gene vary in structure and splicing during lymphoid development. (1980) (78)
Somatic rearrangements forming active immunoglobulin mu genes in B and T lymphoid cell lines. (1980) (77)
Variant (6 ; 15) translocation in a murine plasmacytoma occurs near an immunoglobulin κ gene but far from the myc oncogene (1984) (77)
Bcl-w is an important determinant of damage-induced apoptosis in epithelia of small and large intestine (2000) (77)
Transposition of the immunoglobulin heavy chain enhancer to the myc oncogene in a murine plasmacytoma (1985) (75)
Deletions in the constant region locus can account for switches in immunoglobulin heavy chain expression (1980) (75)
The modified 5'-terminal sequences in messenger RNA of mouse myeloma cells. (1975) (74)
Hrk/DP5 contributes to the apoptosis of select neuronal populations but is dispensable for haematopoietic cell apoptosis (2007) (71)
A very large repeating unit of mouse DNA containing the 18S, 28S and 5.8S rRNA genes (1977) (70)
Untranslated Nucleotide Sequence at the 5′-End of R 17 Bacteriophage RNA (1970) (68)
Expression of the c-myc oncogene under control of an immunoglobulin enhancer in E mu-myc transgenic mice (1987) (65)
Endogenous bcl-2 is not required for the development of Emu-myc-induced B-cell lymphoma. (2007) (59)
Survival activity of Bcl-2 homologs Bcl-w and A1 only partially correlates with their ability to bind pro-apoptotic family members (1999) (57)
Sets of immunoglobulin V kappa genes homologous to ten cloned V kappa sequences: implications for the number of germline V kappa genes. (1981) (56)
Bfk: a novel weakly proapoptotic member of the Bcl-2 protein family with a BH3 and a BH2 region (2003) (55)
Interchromosomal recombination of the cellular oncogene c‐myc with the immunoglobulin heavy chain locus in murine plasmacytomas is a reciprocal exchange. (1983) (55)
Discovery of potent and selective benzothiazole hydrazone inhibitors of Bcl-XL. (2013) (55)
Endogenous Bcl-xL is essential for Myc-driven lymphomagenesis in mice. (2011) (52)
Differential Targeting of Prosurvival Bcl-2 Proteins by Their BH 3-Only Ligands Allows Complementary Apoptotic (2005) (52)
Generation of altered transcripts by retroviral insertion within the c-myb gene in two murine monocytic leukemias (1987) (50)
The organization and expression of immunoglobulin genes. (1980) (50)
Enhanced stability of Mcl1, a prosurvival Bcl2 relative, blunts stress-induced apoptosis, causes male sterility, and promotes tumorigenesis (2013) (48)
Oncogene cooperation in lymphocyte transformation: malignant conversion of E mu-myc transgenic pre-B cells in vitro is enhanced by v-H-ras or v-raf but not v-abl (1989) (48)
mRNA for surface immunoglobulin gamma chains encodes a highly conserved transmembrane sequence and a 28-residue intracellular domain. (1982) (48)
Retroviral infection accelerates T lymphomagenesis in E mu-N-ras transgenic mice by activating c-myc or N-myc. (1992) (47)
Enforced BCL 2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease ( oncogene / transgenic mice / lymphocyte lifespan / lupus mkce / glomerulonephritis ) (47)
Untranslated Nucleotide Sequences in R17 Bacteriophage RNA (1970) (46)
Overexpressed max is not oncogenic and attenuates myc-induced lymphoproliferation and lymphomagenesis in transgenic mice. (1995) (42)
Cloned pairs of variable region genes for immunoglobulin heavy chains isolated from a clone library of the entire mouse genome. (1979) (41)
Control of apoptosis in hematopoietic cells by the Bcl-2 family of proteins. (1999) (41)
Intervening sequences divide the gene for the constant region of mouse immunoglobulin mu chains into segments, each encoding a domain. (1980) (41)
Apoptosis and non-inflammatory phagocytosis can be induced by mitochondrial damage without caspases (2010) (40)
Lymphomagenesis in E mu-myc transgenic mice can involve ras mutations. (1989) (39)
Organization of genes and spacers within the mouse immunoglobulin VH locus. (1981) (39)
The ABCs of cancer stem cell drug resistance. (2010) (37)
Organization and Expression of Murine Immunoglobulin Genes (1981) (36)
Enforced expression of Hlx homeobox gene prompts myeloid cell maturation and altered adherence properties of T cells. (1993) (36)
Plasmacytomas with more than one immunoglobulin kappa mRNA: implications for allelic exclusion. (1981) (35)
Fusion of DNA region to murine immunoglobulin heavy chain locus corresponds to plasmacytoma‐associated chromosome translocation. (1983) (35)
Subversion of the Bcl-2 life/death switch in cancer development and therapy. (2005) (35)
Pro-apoptotic BH3-only Bcl-2 family members in vertebrate model organisms suitable for genetic experimentation (2002) (34)
Oncogenic intelligence: Oncogene activation by fusion of chromosomes in leukaemia (1985) (33)
The Role of the Pro‐Apoptotic Bcl‐2 Family Member Bim in Physiological Cell Death (2000) (32)
Perturbed development of T and B cells in mice expressing an Hlx homeobox transgene. (1995) (32)
B-lymphoid to granulocytic switch during hematopoiesis in a transgenic mouse strain. (1994) (32)
Apaf-1 and caspase-9 are required for cytokine withdrawal-induced apoptosis of mast cells but dispensable for their functional and clonogenic death. (2006) (30)
Sequence of 51 nucleotides at the 3'-end of R17 bacteriophage RNA. (1972) (29)
Destruction of tumor vasculature and abated tumor growth upon VEGF blockade is driven by proapoptotic protein Bim in endothelial cells (2011) (29)
BAX Activation: Mutations Near Its Proposed Non-canonical BH3 Binding Site Reveal Allosteric Changes Controlling Mitochondrial Association. (2019) (28)
A search for messenger RNA molecules bearing immunoglobulin VH nucleotide sequences in T cells (1982) (26)
Lessons from bcl-2 transgenic mice for immunology, cancer biology and cell death research. (1996) (24)
Modified nucleosides and 5'-end groups in purified mouse immunoglobulin light chain mRNA and rabbit globin mRNA detected by borohydride labelling. (1976) (22)
Books for the Millions: A History of the Men Whose Methods and Machines Packaged the Printed Word (1974) (22)
Myc oncogene activation in B and T lymphoid tumours (1985) (22)
Generation of long mRNA for membrane immunoglobulin γ2a chains by differential splicing (1981) (22)
Activation of immunoglobulin mu gene expression involves stepwise demethylation. (1984) (20)
Supplemental Data Bak Activation for Apoptosis Involves Oligomerization of Dimers via Their α6 Helices (2008) (20)
Response to Comment on "Tumor Growth Need Not Be Driven by Rare Cancer Stem Cells" (2007) (20)
Functional antagonism between pro-apoptotic BIM and anti-apoptotic BCL-XL in MYC-induced lymphomagenesis (2014) (20)
Clonal hematopoiesis, myeloid disorders and BAX-mutated myelopoiesis in patients receiving venetoclax for CLL. (2021) (19)
Robust autoactivation for apoptosis by BAK but not BAX highlights BAK as an important therapeutic target (2020) (16)
Immunologic competence of B cells subjected to constitutive c-myc oncogene expression in immunoglobulin heavy chain enhancer myc transgenic mice. (1987) (16)
Critical B-lymphoid cell intrinsic role of endogenous MCL-1 in c-MYC-induced lymphomagenesis (2016) (15)
Prophylactic treatment with the BH3 mimetic ABT-737 impedes Myc-driven lymphomagenesis in mice (2012) (15)
Transplanted Hypothalamic Neurons Restore Leptin Signaling and Ameliorate Obesity in db/db Mice (2011) (14)
Potent efficacy of MCL-1 inhibitor-based therapies in preclinical models of mantle cell lymphoma (2019) (14)
Recombination events near the immunoglobulin Cmu gene join variable and constant region genes, switch heavy-chain expression, or inactivate the locus. (1981) (14)
c-myc-induced lymphomagenesis in transgenic mice and the role of the Pvt-1 locus in lymphoid neoplasia. (1986) (14)
Moloney virus induction of T‐cell lymphomas in a plasmacytomagenic strain of Eμ‐V‐ABL transgenic mice (1993) (13)
The Bcl-2-regulated apoptosis switch: mechanism and therapeutic potential (2009) (12)
Detection of a possible precursor of immunoglobulin light chain in MOPC 41 a plasmacytoma cells (1975) (12)
Retroviral transduction of enriched hematopoietic stem cells allows lifelong Bcl-2 expression in multiple lineages but does not perturb hematopoiesis. (1999) (12)
corrigenda: BH3-only Bcl-2 family member Bim is required for apoptosis of autoreactive thymocytes (2002) (11)
Lymphoid tumorigenesis by v-abl and BCR-v-abl in transgenic mice. (1990) (11)
Identical 3′ non-coding sequences in five mouse Ig κ chain mRNAs favour a unique Cκ gene (1979) (11)
Cloned embryonic DNA sequences flanking the mouse immunoglobulin C gamma 3 and C gamma 1 genes. (1980) (10)
NMR studies of interactions between Bax and BH3 domain-containing peptides in the absence and presence of CHAPS. (2014) (10)
BAX and BAK become killers without a BH3 trigger (2019) (9)
Activation of the c-myc oncogene in B and T lymphoid tumors. (1984) (9)
The myc oncogene and lymphoid neoplasia: from translocations to transgenic mice. (1987) (9)
By reducing global mRNA translation in several ways, 2-deoxyglucose lowers MCL-1 protein and sensitizes hemopoietic tumor cells to BH3 mimetic ABT737 (2018) (8)
Gamma-radiation-induced growth arrest and apoptosis in p53-null lymphoma cells is accompanied by modest transcriptional changes in many genes. (2000) (7)
Translation of immunoglobulin mRNAs in a wheat germ cell-free system (1974) (7)
Therapeutic potential of a peptide targeting BCL-2 cell guardians in cancer. (2012) (6)
Organization of the sequences flanking immunoglobulin heavy chain genes and their role in class switching. (1980) (6)
Nucleotide sequence ofbup, an upstream gene in thebmi-1 proviral insertion locus (2005) (6)
Cyclin D1 as the putative bcl-1 oncogene. (1995) (6)
BAX mitochondrial integration is regulated allosterically by its α1−α2 loop (2021) (5)
Generation ofAltered Transcripts byRetroviral Insertion within the c-mybGeneinTwoMurineMonocytic Leukemias (1987) (5)
Plasmacytomas with more than one immunoglobulin K mRNA : Implications for allelic exclusion ( VK cDNA (4)
Immunoglobulin JH rearrangement in a T-cell line reflects fusion to the DH locus at a sequence lacking the nonamer recognition signal (2004) (4)
A Joint Odyssey into Cancer Genetics (2019) (4)
Modified 5′-termini in small nuclear RNAs of mouse myeloma cells (1975) (4)
Synthesis of complementary RNA on RNA templates using the DNA-dependent RNA polymerase of Escherichia coli. (1977) (4)
Acquired mutations in BAX confer resistance to BH3-mimetic therapy in Acute Myeloid Leukemia. (2022) (4)
The transgenic window on lymphoid malignancy. (1989) (4)
Expression of the immunoglobulin C , gene in mouse T and B lymphoid and myeloid cell lines ( p and K mRNA species / hibridization / recombinant DNA / rearranged genes ) (4)
Comparison of immunoglobulin chains made in ascites extract and reticulocyte lysate programmed with mRNA from four mouse myelomas. (1977) (2)
Oncogene cooperation and B-lymphoid tumorigenesis in Emu-myc transgenic mice. (1989) (2)
Robust autoactivation for apoptosis by BAK but not BAX highlights BAK as an important therapeutic target (2020) (2)
Lymphomagenesis in Emu-myc transgenic mice does not require transgene rearrangement or mutation of myc exon 1. (1989) (2)
The influence of immunoglobulin genes in lymphoid oncogenesis. (1986) (2)
Analysis of the leukemogenic properties of the bcr-v-abl and GM-CSF genes using a new retroviral vector. (1989) (2)
deletion and mutation of its DNA-binding domain (2004) (1)
Donald Metcalf: The father of modern hematology (2015) (1)
Number and organisation of immunoglobulin variable region genes in the mouse. (1981) (1)
Decreased cell death and increased self‐renewal: two facets of hematopoietic cell transformation (1992) (1)
Targeting Mcl-1 is a promising strategy to kill mantle cell lymphoma cells (2019) (0)
49 Regulation of Apoptosis by the Bcl-2 Family (2012) (0)
JCB: REPORT (2009) (0)
Contribution of the Cyclin D1 Gene to Lymphomagenesis (1995) (0)
Tâm Mignot Motility Evidence That Focal Adhesion Complexes Power Bacterial Gliding (2013) (0)
By reducing global mRNA translation in several ways, 2-deoxyglucose lowers MCL-1 protein and sensitizes hemopoietic tumor cells to BH3 mimetic ABT737 (2018) (0)
The many roles of apoptotic cell death in the immune system (LL3-6) Chairperson: Shin Yonehara (2010) (0)
Transgenic Window on Haematopoietic Neoplasia (1990) (0)
Generation of long mRNA for membrane immunoglobulin gamma 2a chains by differential splicing. (1981) (0)
Targeting Lymphoid Malignancies with Small Molecule Inhibitors of Pro-Survival Bcl-2 Proteins. (2005) (0)
Lymphoid neoplasia and the control of haemopoietic differentiation. (1989) (0)
Hox 2.4 and a Milieu of High Il-3 Concentration Deliver Synergistic Self-Renewal Signals (1993) (0)
BCL-2 Gene Family (2020) (0)
the Hematopoietic Compartment Drive Transgene Expression In Vivo Throughout vav Promoter Elements of (2010) (0)
Slug Antagonizes p53-Mediated Apoptosis of Hematopoietic Progenitors by Repressing Puma . (2005) (0)
Nucleic Acids Research (2013) (0)
Bak domain swapped dimer induced by BidBH3 with CHAPS (2013) (0)
Erratum: BH3-only Bcl-2 family member Bim is required for apoptosis of autoreactive thymocytes (Nature (2002) 415 (922-926)) (2002) (0)
Role of Bcl-2 Family in Lymphoid Malignancies (2013) (0)
glucocorticoid-induced apoptosis of lymphoid cells in vivo and −-radiation γ BH 3-only proteins Puma and Bim are rate-limiting for (2005) (0)
Constitutive c myc expression and lymphoid neoplasia (1987) (0)
Oncogene impact on haemopoietic cells (1989) (0)
BCL-W expression is an important determinant of damage-induced apoptosis in murine small and large intestinal epithelium in vivo (2000) (0)
Enrichment of specific genes from genomic DNA or from clone library DNA, using R-looping. (1980) (0)
The role of the Bcl-2 protein family in tumorigenesis and cancer therapy (2013) (0)
Author Note: A Joint Odyssey into Cancer Genetics (2019) (0)
How, when, and why do lymphocytes die? (2000) (0)
Frontmatter (1983) (0)
Bax domain swapped dimer in complex with BaxBH3 (2013) (0)
Discovery of BCL-2 as an Oncogene and the First Inhibitor of Apoptosis (2016) (0)
Transgenic Mice as Models for the Development of Haemopoietic Neoplasia (1989) (0)
The cell survival Bcl-w protein is required for spermatogenesis (1998) (0)
death apoptosis of mast cells but dispensable for their functional and clonogenic Apaf-1 and Caspase-9 are required for cytokine withdrawal-induced (2012) (0)
Identical 3' non-coding sequences in five mouse Ig kappa chain mRNAs favour a unique C kappa gene. (1979) (0)
Immortalization of Primitive Hematopoietic-Cells Using Retroviral Gene Delivery (1993) (0)
IN EMBRYOS WHICH INDUCES RESISTANCE IN VITRO TO INFECTION WITH ROUS SARCOMA VIRUS* (0)
Crystal Structures of Human Non-Pancreatic Secreted Phospholipase A2 in Complex With Each of Two Different Inhibitors (1996) (0)
Bax domain swapped dimer induced by octylmaltoside (2013) (0)

This paper list is powered by the following services:

Other Resources About Jerry Adams

What Schools Are Affiliated With Jerry Adams?

Jerry Adams is affiliated with the following schools:

Jerry Adams's Academic­Influence.com Rankings

Jerry Adams's Degrees

Why Is Jerry Adams Influential?

Jerry Adams's Published Works

Published Works

Other Resources About Jerry Adams

What Schools Are Affiliated With Jerry Adams?

Jerry Adams's AcademicInfluence.com Rankings